Matches in Nanopublications for { ?s ?p "DDI between Verapamil and Dabigatran etexilate - Verapamil may increase serum concentrations of the active metabolite(s) of dabigatran etexilate, resulting in an increased risk of bleeding. It is also a strong p-glycoprotein inhibitor. Therapy modification should be considered. [drugbank_resource:DB00661_DB06695]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00661_DB06695 label "DDI between Verapamil and Dabigatran etexilate - Verapamil may increase serum concentrations of the active metabolite(s) of dabigatran etexilate, resulting in an increased risk of bleeding. It is also a strong p-glycoprotein inhibitor. Therapy modification should be considered. [drugbank_resource:DB00661_DB06695]" assertion.